Emcyto is a research-based company focused in development of high quality pharmaceutical products both ANDA and NDA formulations.
It is going to invest more than $ 1 million annually in Research and Development, is developing 3-5 new generic molecules per year.
Our firm is also incubated at NIPER-A and also has access to fully equipped Central Instrumentation Facility at NIPER.